date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.356066051742201.
The log-likelihood improved by 2.747.
Iteration 2 of at most 500:
Optimizing with step length 0.622948079996914.
The log-likelihood improved by 2.204.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.9236.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.04584.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       4       24     1220     1117      769      362      371      384 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     275      185      132       76       45       18       11        5 
degree16 degree17 
       1        1 
1 
disease_progression 
H-positive risk:  844 891 129 892 458 137 848 431 109 68 122 71 
H-negative risk:  891 844 848 892 431 458 137 129 122 109 71 68 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
64 new agents 
2 
disease_progression 
H-positive risk:  845 901 130 890 454 137 848 428 107 66 124 70 
H-negative risk:  901 845 848 890 428 454 137 130 124 107 70 66 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
46 new agents 
3 
disease_progression 
H-positive risk:  852 905 129 885 454 136 849 424 107 66 123 70 
H-negative risk:  905 852 849 885 424 454 136 129 123 107 70 66 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 5 1 

clinical_engagement 
diagnosis 
demography 
51 new agents 
4 
disease_progression 
H-positive risk:  859 916 128 885 449 137 848 422 106 63 121 66 
H-negative risk:  916 859 848 885 422 449 137 128 121 106 66 63 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 6 1 

clinical_engagement 
diagnosis 
demography 
60 new agents 
5 
disease_progression 
H-positive risk:  866 917 128 887 444 138 848 417 108 62 119 66 
H-negative risk:  917 866 848 887 417 444 138 128 119 108 66 62 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 6 1 

clinical_engagement 
diagnosis 
demography 
72 new agents 
6 
disease_progression 
H-positive risk:  876 919 128 883 437 138 854 415 105 61 120 64 
H-negative risk:  919 876 854 883 415 437 138 128 120 105 64 61 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 6 4 

clinical_engagement 
diagnosis 
demography 
58 new agents 
7 
disease_progression 
H-positive risk:  880 915 129 883 433 139 849 419 107 62 121 63 
H-negative risk:  915 880 849 883 419 433 139 129 121 107 63 62 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 7 4 

clinical_engagement 
diagnosis 
demography 
53 new agents 
8 
disease_progression 
H-positive risk:  885 915 130 882 432 142 845 420 107 58 121 63 
H-negative risk:  915 885 845 882 420 432 142 130 121 107 63 58 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 8 5 

clinical_engagement 
diagnosis 
demography 
43 new agents 
9 
disease_progression 
H-positive risk:  889 921 129 882 427 143 844 417 106 59 121 62 
H-negative risk:  921 889 844 882 417 427 143 129 121 106 62 59 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 11 5 

clinical_engagement 
diagnosis 
demography 
55 new agents 
10 
disease_progression 
H-positive risk:  885 929 129 885 424 143 845 414 105 59 120 62 
H-negative risk:  929 885 845 885 414 424 143 129 120 105 62 59 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 12 5 

clinical_engagement 
diagnosis 
demography 
50 new agents 
11 
disease_progression 
H-positive risk:  891 935 131 881 417 143 844 410 104 61 121 62 
H-negative risk:  935 891 844 881 410 417 143 131 121 104 62 61 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 12 5 

clinical_engagement 
diagnosis 
demography 
53 new agents 
12 
disease_progression 
H-positive risk:  887 941 130 889 415 144 844 403 106 58 121 62 
H-negative risk:  941 887 844 889 403 415 144 130 121 106 62 58 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 12 5 

clinical_engagement 
diagnosis 
demography 
60 new agents 
13 
disease_progression 
H-positive risk:  800 862 118 969 410 139 940 397 112 57 134 62 
H-negative risk:  862 800 940 969 397 410 139 118 134 112 62 57 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 12 4 

clinical_engagement 
diagnosis 
demography 
238 new agents 
14 
disease_progression 
H-positive risk:  836 888 123 912 437 140 915 399 101 63 127 59 
H-negative risk:  888 836 915 912 399 437 140 123 127 101 59 63 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 16 3 

clinical_engagement 
diagnosis 
demography 
59 new agents 
15 
disease_progression 
H-positive risk:  849 893 123 897 433 140 916 399 101 63 124 62 
H-negative risk:  893 849 916 897 399 433 140 123 124 101 62 63 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 18 3 

clinical_engagement 
diagnosis 
demography 
58 new agents 
16 
disease_progression 
H-positive risk:  854 899 125 894 432 140 914 394 101 64 122 61 
H-negative risk:  899 854 914 894 394 432 140 125 122 101 61 64 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 19 3 

clinical_engagement 
diagnosis 
demography 
71 new agents 
17 
disease_progression 
H-positive risk:  856 904 126 896 428 139 910 396 101 63 120 61 
H-negative risk:  904 856 910 896 396 428 139 126 120 101 61 63 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 21 4 

clinical_engagement 
diagnosis 
demography 
69 new agents 
18 
disease_progression 
H-positive risk:  858 906 126 902 424 140 903 396 101 64 118 62 
H-negative risk:  906 858 903 902 396 424 140 126 118 101 62 64 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 21 4 

clinical_engagement 
diagnosis 
demography 
51 new agents 
19 
disease_progression 
H-positive risk:  862 910 125 893 427 142 900 394 101 66 118 62 
H-negative risk:  910 862 900 893 394 427 142 125 118 101 62 66 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 22 4 

clinical_engagement 
diagnosis 
demography 
63 new agents 
20 
disease_progression 
H-positive risk:  863 917 127 885 429 141 894 397 102 64 118 63 
H-negative risk:  917 863 894 885 397 429 141 127 118 102 63 64 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 25 5 

clinical_engagement 
diagnosis 
demography 
70 new agents 
21 
disease_progression 
H-positive risk:  865 918 128 882 429 140 898 391 102 65 119 63 
H-negative risk:  918 865 898 882 391 429 140 128 119 102 63 65 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 27 6 

clinical_engagement 
diagnosis 
demography 
61 new agents 
22 
disease_progression 
H-positive risk:  869 924 128 873 423 144 897 387 107 64 121 63 
H-negative risk:  924 869 897 873 387 423 144 128 121 107 63 64 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 28 8 

clinical_engagement 
diagnosis 
demography 
74 new agents 
23 
disease_progression 
H-positive risk:  868 927 130 870 421 143 893 392 108 64 119 65 
H-negative risk:  927 868 893 870 392 421 143 130 119 108 65 64 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 29 9 

clinical_engagement 
diagnosis 
demography 
58 new agents 
24 
disease_progression 
H-positive risk:  877 929 131 870 412 144 893 390 108 63 119 64 
H-negative risk:  929 877 893 870 390 412 144 131 119 108 64 63 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 29 10 

clinical_engagement 
diagnosis 
demography 
73 new agents 
25 
disease_progression 
H-positive risk:  820 859 117 947 403 140 955 383 116 63 135 62 
H-negative risk:  859 820 955 947 383 403 140 117 135 116 62 63 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 31 10 

clinical_engagement 
diagnosis 
demography 
176 new agents 
26 
disease_progression 
H-positive risk:  842 877 121 910 420 144 926 390 111 70 124 65 
H-negative risk:  877 842 926 910 390 420 144 121 124 111 65 70 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 36 10 

clinical_engagement 
diagnosis 
demography 
73 new agents 
27 
disease_progression 
H-positive risk:  850 882 121 911 414 143 922 386 110 71 124 66 
H-negative risk:  882 850 922 911 386 414 143 121 124 110 66 71 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 37 10 

clinical_engagement 
diagnosis 
demography 
77 new agents 
28 
disease_progression 
H-positive risk:  858 886 123 913 415 143 915 379 108 71 125 64 
H-negative risk:  886 858 915 913 379 415 143 123 125 108 64 71 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 40 10 

clinical_engagement 
diagnosis 
demography 
77 new agents 
29 
disease_progression 
H-positive risk:  864 893 123 914 414 141 908 374 107 71 127 64 
H-negative risk:  893 864 908 914 374 414 141 123 127 107 64 71 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 42 9 

clinical_engagement 
diagnosis 
demography 
68 new agents 
30 
disease_progression 
H-positive risk:  871 892 123 913 419 141 905 370 107 69 127 63 
H-negative risk:  892 871 905 913 370 419 141 123 127 107 63 69 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 43 11 

clinical_engagement 
diagnosis 
demography 
59 new agents 
31 
disease_progression 
H-positive risk:  865 908 125 912 412 143 901 369 107 70 125 63 
H-negative risk:  908 865 901 912 369 412 143 125 125 107 63 70 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 42 13 

clinical_engagement 
diagnosis 
demography 
65 new agents 
32 
disease_progression 
H-positive risk:  873 913 123 913 408 143 906 366 104 65 125 61 
H-negative risk:  913 873 906 913 366 408 143 123 125 104 61 65 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 42 13 

clinical_engagement 
diagnosis 
demography 
50 new agents 
33 
disease_progression 
H-positive risk:  881 908 124 917 408 142 902 363 102 65 125 63 
H-negative risk:  908 881 902 917 363 408 142 124 125 102 63 65 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 46 13 

clinical_engagement 
diagnosis 
demography 
63 new agents 
34 
disease_progression 
H-positive risk:  884 911 127 917 399 144 896 370 102 65 122 63 
H-negative risk:  911 884 896 917 370 399 144 127 122 102 63 65 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 47 13 

clinical_engagement 
diagnosis 
demography 
71 new agents 
35 
disease_progression 
H-positive risk:  879 911 129 916 408 146 891 365 104 66 123 62 
H-negative risk:  911 879 891 916 365 408 146 129 123 104 62 66 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 47 14 

clinical_engagement 
diagnosis 
demography 
67 new agents 
36 
disease_progression 
H-positive risk:  884 910 126 913 407 147 899 363 100 68 121 62 
H-negative risk:  910 884 899 913 363 407 147 126 121 100 62 68 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 48 14 

clinical_engagement 
diagnosis 
demography 
47 new agents 
37 
disease_progression 
H-positive risk:  813 847 122 972 403 138 974 366 111 68 124 62 
H-negative risk:  847 813 974 972 366 403 138 122 124 111 62 68 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 49 15 

clinical_engagement 
diagnosis 
demography 
172 new agents 
38 
disease_progression 
H-positive risk:  831 872 123 942 407 138 950 373 107 74 125 58 
H-negative risk:  872 831 950 942 373 407 138 123 125 107 58 74 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 55 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
39 
disease_progression 
H-positive risk:  836 873 126 939 409 137 948 374 106 70 122 60 
H-negative risk:  873 836 948 939 374 409 137 126 122 106 60 70 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 54 15 

clinical_engagement 
diagnosis 
demography 
64 new agents 
40 
disease_progression 
H-positive risk:  836 883 129 939 399 136 947 370 105 70 125 61 
H-negative risk:  883 836 947 939 370 399 136 129 125 105 61 70 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 54 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
41 
disease_progression 
H-positive risk:  840 885 130 939 395 134 953 367 103 68 124 62 
H-negative risk:  885 840 953 939 367 395 134 130 124 103 62 68 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 55 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
42 
disease_progression 
H-positive risk:  841 895 130 935 396 134 949 364 106 67 120 63 
H-negative risk:  895 841 949 935 364 396 134 130 120 106 63 67 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 55 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
43 
disease_progression 
H-positive risk:  846 902 132 933 391 128 945 364 111 64 120 64 
H-negative risk:  902 846 945 933 364 391 128 132 120 111 64 64 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 56 20 

clinical_engagement 
diagnosis 
demography 
55 new agents 
44 
disease_progression 
H-positive risk:  843 902 135 930 387 128 947 369 113 64 121 61 
H-negative risk:  902 843 947 930 369 387 128 135 121 113 61 64 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 58 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
45 
disease_progression 
H-positive risk:  854 902 136 924 383 131 956 359 113 61 121 60 
H-negative risk:  902 854 956 924 359 383 131 136 121 113 60 61 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 61 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
46 
disease_progression 
H-positive risk:  853 915 135 923 378 134 954 355 113 60 120 60 
H-negative risk:  915 853 954 923 355 378 134 135 120 113 60 60 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
47 
disease_progression 
H-positive risk:  852 916 136 922 375 134 962 357 111 58 120 57 
H-negative risk:  916 852 962 922 357 375 134 136 120 111 57 58 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 64 20 

clinical_engagement 
diagnosis 
demography 
60 new agents 
48 
disease_progression 
H-positive risk:  859 923 135 914 378 132 958 356 111 58 120 56 
H-negative risk:  923 859 958 914 356 378 132 135 120 111 56 58 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 67 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
49 
disease_progression 
H-positive risk:  791 853 126 986 378 122 1021 355 125 58 130 55 
H-negative risk:  853 791 1021 986 355 378 122 126 130 125 55 58 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
122 new agents 
50 
disease_progression 
H-positive risk:  798 871 126 963 391 124 977 388 120 61 126 55 
H-negative risk:  871 798 977 963 388 391 124 126 126 120 55 61 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
51 
disease_progression 
H-positive risk:  797 872 125 959 386 128 977 397 119 58 129 53 
H-negative risk:  872 797 977 959 397 386 128 125 129 119 53 58 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
52 
disease_progression 
H-positive risk:  801 874 124 958 383 127 980 395 119 58 128 53 
H-negative risk:  874 801 980 958 395 383 127 124 128 119 53 58 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
53 
disease_progression 
H-positive risk:  803 875 123 960 382 128 982 389 120 57 129 52 
H-negative risk:  875 803 982 960 389 382 128 123 129 120 52 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
54 
disease_progression 
H-positive risk:  806 876 123 965 375 130 981 389 120 56 127 52 
H-negative risk:  876 806 981 965 389 375 130 123 127 120 52 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
53 new agents 
55 
disease_progression 
H-positive risk:  811 877 125 967 370 130 977 390 119 55 127 52 
H-negative risk:  877 811 977 967 390 370 130 125 127 119 52 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
56 
disease_progression 
H-positive risk:  818 874 126 957 371 132 984 387 120 51 128 52 
H-negative risk:  874 818 984 957 387 371 132 126 128 120 52 51 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
58 new agents 
57 
disease_progression 
H-positive risk:  813 878 123 949 370 131 990 389 121 53 132 51 
H-negative risk:  878 813 990 949 389 370 131 123 132 121 51 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
58 
disease_progression 
H-positive risk:  819 882 123 943 366 133 992 384 124 51 131 52 
H-negative risk:  882 819 992 943 384 366 133 123 131 124 52 51 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
59 
disease_progression 
H-positive risk:  824 883 124 936 363 132 997 386 119 51 133 52 
H-negative risk:  883 824 997 936 386 363 132 124 133 119 52 51 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
60 
disease_progression 
H-positive risk:  821 885 124 942 359 131 1007 376 117 51 135 52 
H-negative risk:  885 821 1007 942 376 359 131 124 135 117 52 51 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
61 
disease_progression 
H-positive risk:  774 823 116 995 365 122 1058 370 133 52 140 52 
H-negative risk:  823 774 1058 995 370 365 122 116 140 133 52 52 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
137 new agents 
62 
disease_progression 
H-positive risk:  779 834 117 978 363 123 1041 393 135 50 140 47 
H-negative risk:  834 779 1041 978 393 363 123 117 140 135 47 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 75 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
63 
disease_progression 
H-positive risk:  775 841 117 977 362 122 1044 387 138 49 141 47 
H-negative risk:  841 775 1044 977 387 362 122 117 141 138 47 49 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
90 new agents 
64 
disease_progression 
H-positive risk:  766 844 122 984 357 121 1041 385 141 50 143 46 
H-negative risk:  844 766 1041 984 385 357 121 122 143 141 46 50 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
65 
disease_progression 
H-positive risk:  772 843 122 984 355 123 1038 382 142 50 142 47 
H-negative risk:  843 772 1038 984 382 355 123 122 142 142 47 50 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
66 
disease_progression 
H-positive risk:  771 846 124 985 356 124 1033 382 138 52 146 43 
H-negative risk:  846 771 1033 985 382 356 124 124 146 138 43 52 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
67 
disease_progression 
H-positive risk:  772 851 125 974 364 127 1030 378 137 52 145 45 
H-negative risk:  851 772 1030 974 378 364 127 125 145 137 45 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
68 
disease_progression 
H-positive risk:  770 858 126 969 361 128 1029 377 140 52 145 45 
H-negative risk:  858 770 1029 969 377 361 128 126 145 140 45 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
69 
disease_progression 
H-positive risk:  774 861 129 968 359 129 1021 374 140 55 144 46 
H-negative risk:  861 774 1021 968 374 359 129 129 144 140 46 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
70 
disease_progression 
H-positive risk:  775 859 128 977 368 127 1014 369 140 52 144 47 
H-negative risk:  859 775 1014 977 369 368 127 128 144 140 47 52 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
71 
disease_progression 
H-positive risk:  771 854 127 981 361 133 1020 365 142 55 144 47 
H-negative risk:  854 771 1020 981 365 361 133 127 144 142 47 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
72 
disease_progression 
H-positive risk:  775 856 128 973 367 135 1018 366 138 52 145 47 
H-negative risk:  856 775 1018 973 366 367 135 128 145 138 47 52 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
73 
disease_progression 
H-positive risk:  737 810 119 1020 372 131 1046 365 148 50 155 47 
H-negative risk:  810 737 1046 1020 365 372 131 119 155 148 47 50 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
114 new agents 
74 
disease_progression 
H-positive risk:  742 813 120 998 390 132 1016 391 148 45 158 47 
H-negative risk:  813 742 1016 998 391 390 132 120 158 148 47 45 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
75 
disease_progression 
H-positive risk:  738 822 121 1000 385 133 1022 385 147 44 156 47 
H-negative risk:  822 738 1022 1000 385 385 133 121 156 147 47 44 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
76 
disease_progression 
H-positive risk:  745 819 122 1007 380 133 1019 384 145 45 154 47 
H-negative risk:  819 745 1019 1007 384 380 133 122 154 145 47 45 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
55 new agents 
77 
disease_progression 
H-positive risk:  749 817 121 1005 378 129 1024 387 144 45 155 46 
H-negative risk:  817 749 1024 1005 387 378 129 121 155 144 46 45 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
78 
disease_progression 
H-positive risk:  744 818 123 1009 378 127 1031 384 142 44 151 49 
H-negative risk:  818 744 1031 1009 384 378 127 123 151 142 49 44 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
79 
disease_progression 
H-positive risk:  749 821 122 1013 370 127 1034 380 144 42 149 49 
H-negative risk:  821 749 1034 1013 380 370 127 122 149 144 49 42 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
80 
disease_progression 
H-positive risk:  750 829 120 1011 362 127 1030 385 148 41 148 49 
H-negative risk:  829 750 1030 1011 385 362 127 120 148 148 49 41 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
60 new agents 
81 
disease_progression 
H-positive risk:  759 826 119 1011 361 128 1025 384 148 42 146 51 
H-negative risk:  826 759 1025 1011 384 361 128 119 146 148 51 42 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
82 
disease_progression 
H-positive risk:  765 821 118 1006 358 127 1028 386 149 43 146 53 
H-negative risk:  821 765 1028 1006 386 358 127 118 146 149 53 43 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
83 
disease_progression 
H-positive risk:  774 821 119 1008 352 126 1024 381 148 44 150 53 
H-negative risk:  821 774 1024 1008 381 352 126 119 150 148 53 44 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
84 
disease_progression 
H-positive risk:  774 819 120 1004 352 128 1024 383 149 43 151 53 
H-negative risk:  819 774 1024 1004 383 352 128 120 151 149 53 43 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
53 new agents 
85 
disease_progression 
H-positive risk:  733 773 113 1053 355 122 1064 373 155 43 162 54 
H-negative risk:  773 733 1064 1053 373 355 122 113 162 155 54 43 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
117 new agents 
86 
disease_progression 
H-positive risk:  741 774 109 1041 367 123 1054 378 151 47 164 51 
H-negative risk:  774 741 1054 1041 378 367 123 109 164 151 51 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
87 
disease_progression 
H-positive risk:  749 769 110 1032 370 123 1049 381 149 50 166 52 
H-negative risk:  769 749 1049 1032 381 370 123 110 166 149 52 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
88 
disease_progression 
H-positive risk:  749 768 110 1027 367 121 1061 377 148 50 168 54 
H-negative risk:  768 749 1061 1027 377 367 121 110 168 148 54 50 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
58 new agents 
89 
disease_progression 
H-positive risk:  745 774 110 1028 365 119 1060 376 149 48 170 56 
H-negative risk:  774 745 1060 1028 376 365 119 110 170 149 56 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
90 
disease_progression 
H-positive risk:  745 777 113 1025 363 118 1060 377 150 48 169 55 
H-negative risk:  777 745 1060 1025 377 363 118 113 169 150 55 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
91 
disease_progression 
H-positive risk:  736 774 112 1036 366 116 1065 372 155 47 170 51 
H-negative risk:  774 736 1065 1036 372 366 116 112 170 155 51 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
92 
disease_progression 
H-positive risk:  744 779 116 1033 369 115 1066 361 152 45 169 51 
H-negative risk:  779 744 1066 1033 361 369 115 116 169 152 51 45 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
93 
disease_progression 
H-positive risk:  745 784 116 1031 367 115 1065 360 150 47 170 50 
H-negative risk:  784 745 1065 1031 360 367 115 116 170 150 50 47 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
59 new agents 
94 
disease_progression 
H-positive risk:  747 777 111 1036 368 117 1060 363 152 47 175 47 
H-negative risk:  777 747 1060 1036 363 368 117 111 175 152 47 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
55 new agents 
95 
disease_progression 
H-positive risk:  746 780 110 1037 372 118 1054 366 150 47 175 45 
H-negative risk:  780 746 1054 1037 366 372 118 110 175 150 45 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
96 
disease_progression 
H-positive risk:  744 770 109 1045 367 116 1062 363 157 47 174 46 
H-negative risk:  770 744 1062 1045 363 367 116 109 174 157 46 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
97 
disease_progression 
H-positive risk:  704 729 108 1091 377 102 1092 361 168 46 176 46 
H-negative risk:  729 704 1092 1091 361 377 102 108 176 168 46 46 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
98 
disease_progression 
H-positive risk:  693 726 107 1093 376 97 1085 380 169 49 173 52 
H-negative risk:  726 693 1085 1093 380 376 97 107 173 169 52 49 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
99 
disease_progression 
H-positive risk:  688 723 109 1090 379 97 1091 380 168 51 169 55 
H-negative risk:  723 688 1091 1090 380 379 97 109 169 168 55 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
100 
disease_progression 
H-positive risk:  685 730 106 1087 375 98 1086 388 163 50 174 58 
H-negative risk:  730 685 1086 1087 388 375 98 106 174 163 58 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
101 
disease_progression 
H-positive risk:  690 727 109 1089 372 100 1080 391 164 46 173 59 
H-negative risk:  727 690 1080 1089 391 372 100 109 173 164 59 46 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
102 
disease_progression 
H-positive risk:  686 726 110 1093 373 103 1081 387 165 45 171 60 
H-negative risk:  726 686 1081 1093 387 373 103 110 171 165 60 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
103 
disease_progression 
H-positive risk:  693 722 110 1086 379 104 1074 390 162 48 174 58 
H-negative risk:  722 693 1074 1086 390 379 104 110 174 162 58 48 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
55 new agents 
104 
disease_progression 
H-positive risk:  688 724 111 1089 377 105 1067 400 159 49 172 59 
H-negative risk:  724 688 1067 1089 400 377 105 111 172 159 59 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
105 
disease_progression 
H-positive risk:  684 728 113 1093 373 105 1066 398 159 51 169 61 
H-negative risk:  728 684 1066 1093 398 373 105 113 169 159 61 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
106 
disease_progression 
H-positive risk:  683 732 116 1084 379 108 1070 389 162 48 168 61 
H-negative risk:  732 683 1070 1084 389 379 108 116 168 162 61 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
107 
disease_progression 
H-positive risk:  688 729 114 1084 375 108 1077 391 161 46 167 60 
H-negative risk:  729 688 1077 1084 391 375 108 114 167 161 60 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
108 
disease_progression 
H-positive risk:  692 728 114 1084 373 111 1086 381 158 46 166 61 
H-negative risk:  728 692 1086 1084 381 373 111 114 166 158 61 46 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
109 
disease_progression 
H-positive risk:  657 690 99 1127 367 101 1134 374 161 48 181 61 
H-negative risk:  690 657 1134 1127 374 367 101 99 181 161 61 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
108 new agents 
110 
disease_progression 
H-positive risk:  666 684 100 1123 370 101 1126 385 156 50 176 63 
H-negative risk:  684 666 1126 1123 385 370 101 100 176 156 63 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
111 
disease_progression 
H-positive risk:  678 685 98 1115 377 101 1118 387 155 50 175 61 
H-negative risk:  685 678 1118 1115 387 377 101 98 175 155 61 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
112 
disease_progression 
H-positive risk:  676 692 100 1105 379 103 1113 393 156 48 175 60 
H-negative risk:  692 676 1113 1105 393 379 103 100 175 156 60 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
113 
disease_progression 
H-positive risk:  679 699 99 1110 375 104 1096 396 156 47 175 64 
H-negative risk:  699 679 1096 1110 396 375 104 99 175 156 64 47 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
114 
disease_progression 
H-positive risk:  683 702 99 1108 370 103 1094 396 160 47 174 64 
H-negative risk:  702 683 1094 1108 396 370 103 99 174 160 64 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
115 
disease_progression 
H-positive risk:  690 699 97 1115 376 101 1092 390 157 46 177 60 
H-negative risk:  699 690 1092 1115 390 376 101 97 177 157 60 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
116 
disease_progression 
H-positive risk:  694 690 95 1128 369 102 1086 398 157 49 175 57 
H-negative risk:  690 694 1086 1128 398 369 102 95 175 157 57 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
117 
disease_progression 
H-positive risk:  699 691 94 1134 371 101 1076 396 155 51 174 58 
H-negative risk:  691 699 1076 1134 396 371 101 94 174 155 58 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
118 
disease_progression 
H-positive risk:  706 694 90 1140 367 103 1075 388 154 50 175 58 
H-negative risk:  694 706 1075 1140 388 367 103 90 175 154 58 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
119 
disease_progression 
H-positive risk:  702 705 92 1141 361 100 1072 387 157 52 174 57 
H-negative risk:  705 702 1072 1141 387 361 100 92 174 157 57 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
120 
disease_progression 
H-positive risk:  701 703 93 1139 364 101 1077 380 157 49 178 58 
H-negative risk:  703 701 1077 1139 380 364 101 93 178 157 58 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
121 
disease_progression 
H-positive risk:  667 656 90 1191 357 94 1105 385 165 49 183 58 
H-negative risk:  656 667 1105 1191 385 357 94 90 183 165 58 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
93 new agents 
122 
disease_progression 
H-positive risk:  657 663 88 1175 368 94 1096 401 160 53 180 65 
H-negative risk:  663 657 1096 1175 401 368 94 88 180 160 65 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
123 
disease_progression 
H-positive risk:  656 662 87 1171 371 95 1087 414 158 55 179 65 
H-negative risk:  662 656 1087 1171 414 371 95 87 179 158 65 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
124 
disease_progression 
H-positive risk:  656 661 86 1178 370 95 1084 418 156 56 179 61 
H-negative risk:  661 656 1084 1178 418 370 95 86 179 156 61 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
57 new agents 
125 
disease_progression 
H-positive risk:  661 667 86 1175 372 92 1080 419 155 55 177 61 
H-negative risk:  667 661 1080 1175 419 372 92 86 177 155 61 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
126 
disease_progression 
H-positive risk:  659 664 84 1177 369 91 1082 420 156 57 175 66 
H-negative risk:  664 659 1082 1177 420 369 91 84 175 156 66 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
89 new agents 
127 
disease_progression 
H-positive risk:  662 663 83 1175 370 93 1074 419 156 60 178 67 
H-negative risk:  663 662 1074 1175 419 370 93 83 178 156 67 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
128 
disease_progression 
H-positive risk:  668 661 84 1179 367 94 1069 412 159 62 179 66 
H-negative risk:  661 668 1069 1179 412 367 94 84 179 159 66 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
129 
disease_progression 
H-positive risk:  663 663 86 1176 369 93 1068 414 160 61 182 65 
H-negative risk:  663 663 1068 1176 414 369 93 86 182 160 65 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
94 new agents 
130 
disease_progression 
H-positive risk:  671 667 87 1173 367 91 1067 411 163 59 179 65 
H-negative risk:  667 671 1067 1173 411 367 91 87 179 163 65 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 72 34 

clinical_engagement 
diagnosis 
demography 
75 new agents 
131 
disease_progression 
H-positive risk:  676 669 86 1174 365 91 1063 411 162 62 180 61 
H-negative risk:  669 676 1063 1174 411 365 91 86 180 162 61 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 71 37 

clinical_engagement 
diagnosis 
demography 
74 new agents 
132 
disease_progression 
H-positive risk:  672 670 92 1170 369 87 1070 408 158 63 181 60 
H-negative risk:  670 672 1070 1170 408 369 87 92 181 158 60 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 68 37 

clinical_engagement 
diagnosis 
demography 
62 new agents 
133 
disease_progression 
H-positive risk:  668 675 90 1164 368 87 1071 413 161 61 184 58 
H-negative risk:  675 668 1071 1164 413 368 87 90 184 161 58 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 68 37 

clinical_engagement 
diagnosis 
demography 
105 new agents 
134 
disease_progression 
H-positive risk:  667 670 89 1154 378 91 1066 421 159 62 179 64 
H-negative risk:  670 667 1066 1154 421 378 91 89 179 159 64 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 62 37 

clinical_engagement 
diagnosis 
demography 
74 new agents 
135 
disease_progression 
H-positive risk:  662 667 90 1149 387 91 1065 423 160 63 179 64 
H-negative risk:  667 662 1065 1149 423 387 91 90 179 160 64 63 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 61 38 

clinical_engagement 
diagnosis 
demography 
73 new agents 
136 
disease_progression 
H-positive risk:  652 662 88 1166 382 90 1064 425 163 63 180 65 
H-negative risk:  662 652 1064 1166 425 382 90 88 180 163 65 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 64 38 

clinical_engagement 
diagnosis 
demography 
83 new agents 
137 
disease_progression 
H-positive risk:  657 668 89 1160 380 90 1060 428 162 64 179 63 
H-negative risk:  668 657 1060 1160 428 380 90 89 179 162 63 64 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 61 39 

clinical_engagement 
diagnosis 
demography 
72 new agents 
138 
disease_progression 
H-positive risk:  661 663 89 1160 379 88 1074 419 164 63 177 63 
H-negative risk:  663 661 1074 1160 419 379 88 89 177 164 63 63 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 61 38 

clinical_engagement 
diagnosis 
demography 
56 new agents 
139 
disease_progression 
H-positive risk:  655 666 89 1162 383 87 1076 421 163 61 174 63 
H-negative risk:  666 655 1076 1162 421 383 87 89 174 163 63 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 63 37 

clinical_engagement 
diagnosis 
demography 
87 new agents 
140 
disease_progression 
H-positive risk:  658 669 89 1160 384 84 1082 414 166 58 173 63 
H-negative risk:  669 658 1082 1160 414 384 84 89 173 166 63 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 63 34 

clinical_engagement 
diagnosis 
demography 
71 new agents 
141 
disease_progression 
H-positive risk:  656 679 90 1162 379 84 1076 414 165 57 175 63 
H-negative risk:  679 656 1076 1162 414 379 84 90 175 165 63 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 62 34 

clinical_engagement 
diagnosis 
demography 
62 new agents 
142 
disease_progression 
H-positive risk:  665 673 90 1162 372 81 1080 419 166 58 172 62 
H-negative risk:  673 665 1080 1162 419 372 81 90 172 166 62 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 66 34 

clinical_engagement 
diagnosis 
demography 
62 new agents 
143 
disease_progression 
H-positive risk:  669 663 90 1171 373 77 1080 421 165 60 173 58 
H-negative risk:  663 669 1080 1171 421 373 77 90 173 165 58 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 68 35 

clinical_engagement 
diagnosis 
demography 
78 new agents 
144 
disease_progression 
H-positive risk:  667 664 90 1177 373 78 1082 420 163 58 172 56 
H-negative risk:  664 667 1082 1177 420 373 78 90 172 163 56 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 68 35 

clinical_engagement 
diagnosis 
demography 
67 new agents 
145 
disease_progression 
H-positive risk:  671 665 87 1180 373 78 1076 419 162 61 172 56 
H-negative risk:  665 671 1076 1180 419 373 78 87 172 162 56 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 66 34 

clinical_engagement 
diagnosis 
demography 
106 new agents 
146 
disease_progression 
H-positive risk:  675 662 84 1183 368 80 1085 417 161 64 165 56 
H-negative risk:  662 675 1085 1183 417 368 80 84 165 161 56 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 65 33 

clinical_engagement 
diagnosis 
demography 
79 new agents 
147 
disease_progression 
H-positive risk:  673 653 87 1176 379 80 1086 422 159 65 165 55 
H-negative risk:  653 673 1086 1176 422 379 80 87 165 159 55 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 67 34 

clinical_engagement 
diagnosis 
demography 
89 new agents 
148 
disease_progression 
H-positive risk:  679 658 90 1181 371 81 1079 416 158 64 171 52 
H-negative risk:  658 679 1079 1181 416 371 81 90 171 158 52 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
62 new agents 
149 
disease_progression 
H-positive risk:  680 654 90 1178 381 82 1081 411 157 64 169 53 
H-negative risk:  654 680 1081 1178 411 381 82 90 169 157 53 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
85 new agents 
150 
disease_progression 
H-positive risk:  675 653 94 1173 390 83 1088 398 157 65 169 55 
H-negative risk:  653 675 1088 1173 398 390 83 94 169 157 55 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
63 new agents 
151 
disease_progression 
H-positive risk:  664 662 95 1172 389 83 1094 395 156 66 167 57 
H-negative risk:  662 664 1094 1172 395 389 83 95 167 156 57 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
152 
disease_progression 
H-positive risk:  673 663 92 1162 384 84 1104 393 157 63 169 56 
H-negative risk:  663 673 1104 1162 393 384 84 92 169 157 56 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
153 
disease_progression 
H-positive risk:  679 659 89 1153 387 89 1107 385 154 67 175 56 
H-negative risk:  659 679 1107 1153 385 387 89 89 175 154 56 67 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
154 
disease_progression 
H-positive risk:  679 665 93 1153 383 93 1115 372 156 64 171 56 
H-negative risk:  665 679 1115 1153 372 383 93 93 171 156 56 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
155 
disease_progression 
H-positive risk:  680 665 92 1147 387 95 1112 380 156 60 169 57 
H-negative risk:  665 680 1112 1147 380 387 95 92 169 156 57 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
84 new agents 
156 
disease_progression 
H-positive risk:  698 666 95 1144 386 94 1101 369 157 62 171 57 
H-negative risk:  666 698 1101 1144 369 386 94 95 171 157 57 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
59 new agents 
157 
disease_progression 
H-positive risk:  695 661 95 1143 386 95 1109 369 158 60 173 56 
H-negative risk:  661 695 1109 1143 369 386 95 95 173 158 56 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
87 new agents 
158 
disease_progression 
H-positive risk:  690 662 93 1142 388 92 1105 376 157 62 179 54 
H-negative risk:  662 690 1105 1142 376 388 92 93 179 157 54 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 77 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
159 
disease_progression 
H-positive risk:  691 671 92 1133 386 89 1103 379 159 63 183 51 
H-negative risk:  671 691 1103 1133 379 386 89 92 183 159 51 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
103 new agents 
160 
disease_progression 
H-positive risk:  697 671 90 1137 378 88 1110 374 161 61 181 52 
H-negative risk:  671 697 1110 1137 374 378 88 90 181 161 52 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
161 
disease_progression 
H-positive risk:  694 672 92 1123 383 86 1120 374 161 64 178 53 
H-negative risk:  672 694 1120 1123 374 383 86 92 178 161 53 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
162 
disease_progression 
H-positive risk:  687 673 89 1124 378 86 1122 383 161 62 181 54 
H-negative risk:  673 687 1122 1124 383 378 86 89 181 161 54 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
163 
disease_progression 
H-positive risk:  686 675 91 1127 378 86 1118 386 160 61 180 52 
H-negative risk:  675 686 1118 1127 386 378 86 91 180 160 52 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
164 
disease_progression 
H-positive risk:  682 678 92 1129 374 86 1123 385 156 64 180 51 
H-negative risk:  678 682 1123 1129 385 374 86 92 180 156 51 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
165 
disease_progression 
H-positive risk:  685 675 94 1137 372 83 1116 382 160 64 181 51 
H-negative risk:  675 685 1116 1137 382 372 83 94 181 160 51 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
166 
disease_progression 
H-positive risk:  678 678 93 1132 374 83 1123 383 159 62 184 51 
H-negative risk:  678 678 1123 1132 383 374 83 93 184 159 51 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
167 
disease_progression 
H-positive risk:  673 677 95 1137 375 84 1118 385 159 61 186 50 
H-negative risk:  677 673 1118 1137 385 375 84 95 186 159 50 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
168 
disease_progression 
H-positive risk:  675 672 92 1134 375 82 1127 384 163 58 187 51 
H-negative risk:  672 675 1127 1134 384 375 82 92 187 163 51 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
169 
disease_progression 
H-positive risk:  677 672 92 1131 375 82 1123 392 162 57 184 53 
H-negative risk:  672 677 1123 1131 392 375 82 92 184 162 53 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
170 
disease_progression 
H-positive risk:  676 664 92 1129 387 83 1105 410 158 61 177 58 
H-negative risk:  664 676 1105 1129 410 387 83 92 177 158 58 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
171 
disease_progression 
H-positive risk:  677 661 88 1123 398 82 1101 411 158 59 183 59 
H-negative risk:  661 677 1101 1123 411 398 82 88 183 158 59 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
172 
disease_progression 
H-positive risk:  675 655 91 1129 393 85 1104 412 157 58 184 57 
H-negative risk:  655 675 1104 1129 412 393 85 91 184 157 57 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
173 
disease_progression 
H-positive risk:  669 657 95 1131 386 81 1100 422 164 59 180 56 
H-negative risk:  657 669 1100 1131 422 386 81 95 180 164 56 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
174 
disease_progression 
H-positive risk:  670 664 95 1123 385 82 1095 420 167 56 185 58 
H-negative risk:  664 670 1095 1123 420 385 82 95 185 167 58 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
175 
disease_progression 
H-positive risk:  670 660 94 1122 387 84 1105 418 163 54 182 61 
H-negative risk:  660 670 1105 1122 418 387 84 94 182 163 61 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
176 
disease_progression 
H-positive risk:  672 660 91 1133 385 83 1100 414 164 53 183 62 
H-negative risk:  660 672 1100 1133 414 385 83 91 183 164 62 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
177 
disease_progression 
H-positive risk:  678 655 91 1137 388 83 1085 414 169 54 183 63 
H-negative risk:  655 678 1085 1137 414 388 83 91 183 169 63 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
178 
disease_progression 
H-positive risk:  681 653 90 1138 384 83 1081 418 171 54 183 64 
H-negative risk:  653 681 1081 1138 418 384 83 90 183 171 64 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
179 
disease_progression 
H-positive risk:  676 651 87 1141 385 81 1081 416 174 57 183 68 
H-negative risk:  651 676 1081 1141 416 385 81 87 183 174 68 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
180 
disease_progression 
H-positive risk:  664 654 88 1140 385 79 1088 416 180 57 180 69 
H-negative risk:  654 664 1088 1140 416 385 79 88 180 180 69 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
181 
disease_progression 
H-positive risk:  669 662 89 1142 384 81 1073 420 177 56 176 71 
H-negative risk:  662 669 1073 1142 420 384 81 89 176 177 71 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
182 
disease_progression 
H-positive risk:  671 655 91 1147 391 78 1064 420 180 59 173 71 
H-negative risk:  655 671 1064 1147 420 391 78 91 173 180 71 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
183 
disease_progression 
H-positive risk:  668 649 89 1152 390 80 1064 421 182 58 172 75 
H-negative risk:  649 668 1064 1152 421 390 80 89 172 182 75 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
184 
disease_progression 
H-positive risk:  659 651 90 1165 380 80 1064 419 183 62 173 74 
H-negative risk:  651 659 1064 1165 419 380 80 90 173 183 74 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
185 
disease_progression 
H-positive risk:  664 649 89 1161 381 83 1065 415 182 61 175 75 
H-negative risk:  649 664 1065 1161 415 381 83 89 175 182 75 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
186 
disease_progression 
H-positive risk:  665 641 87 1164 384 84 1064 413 182 62 179 75 
H-negative risk:  641 665 1064 1164 413 384 84 87 179 182 75 62 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
187 
disease_progression 
H-positive risk:  666 643 84 1162 384 90 1073 402 180 63 182 71 
H-negative risk:  643 666 1073 1162 402 384 90 84 182 180 71 63 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
188 
disease_progression 
H-positive risk:  668 653 81 1158 381 89 1060 409 181 65 185 70 
H-negative risk:  653 668 1060 1158 409 381 89 81 185 181 70 65 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 97 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
189 
disease_progression 
H-positive risk:  667 652 82 1157 379 88 1065 410 177 67 186 70 
H-negative risk:  652 667 1065 1157 410 379 88 82 186 177 70 67 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 96 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
190 
disease_progression 
H-positive risk:  662 653 82 1168 374 86 1072 405 178 67 182 71 
H-negative risk:  653 662 1072 1168 405 374 86 82 182 178 71 67 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
61 new agents 
191 
disease_progression 
H-positive risk:  666 654 79 1166 377 86 1068 406 178 64 186 70 
H-negative risk:  654 666 1068 1166 406 377 86 79 186 178 70 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
192 
disease_progression 
H-positive risk:  660 659 77 1158 388 85 1069 409 178 60 188 69 
H-negative risk:  659 660 1069 1158 409 388 85 77 188 178 69 60 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
193 
disease_progression 
H-positive risk:  652 657 80 1158 388 84 1080 404 184 57 190 66 
H-negative risk:  657 652 1080 1158 404 388 84 80 190 184 66 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
194 
disease_progression 
H-positive risk:  651 647 80 1159 394 85 1078 410 180 61 191 64 
H-negative risk:  647 651 1078 1159 410 394 85 80 191 180 64 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
195 
disease_progression 
H-positive risk:  661 648 79 1155 397 84 1065 412 181 62 192 64 
H-negative risk:  648 661 1065 1155 412 397 84 79 192 181 64 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
196 
disease_progression 
H-positive risk:  665 641 76 1156 416 83 1058 407 181 62 190 65 
H-negative risk:  641 665 1058 1156 407 416 83 76 190 181 65 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
93 new agents 
197 
disease_progression 
H-positive risk:  665 644 78 1144 417 84 1062 411 181 62 187 65 
H-negative risk:  644 665 1062 1144 411 417 84 78 187 181 65 62 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
198 
disease_progression 
H-positive risk:  669 645 80 1143 407 84 1067 414 177 61 190 63 
H-negative risk:  645 669 1067 1143 414 407 84 80 190 177 63 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
199 
disease_progression 
H-positive risk:  664 646 82 1134 410 86 1081 413 175 62 186 61 
H-negative risk:  646 664 1081 1134 413 410 86 82 186 175 61 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
200 
disease_progression 
H-positive risk:  667 648 84 1130 414 85 1076 415 176 62 185 58 
H-negative risk:  648 667 1076 1130 415 414 85 84 185 176 58 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
201 
disease_progression 
H-positive risk:  670 647 83 1131 410 83 1074 419 178 61 188 56 
H-negative risk:  647 670 1074 1131 419 410 83 83 188 178 56 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
202 
disease_progression 
H-positive risk:  664 643 84 1127 415 82 1082 420 180 61 186 56 
H-negative risk:  643 664 1082 1127 420 415 82 84 186 180 56 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
203 
disease_progression 
H-positive risk:  657 641 85 1132 414 81 1078 429 177 61 189 56 
H-negative risk:  641 657 1078 1132 429 414 81 85 189 177 56 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
204 
disease_progression 
H-positive risk:  652 635 84 1137 416 83 1082 427 175 61 191 57 
H-negative risk:  635 652 1082 1137 427 416 83 84 191 175 57 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
205 
disease_progression 
H-positive risk:  653 640 83 1135 420 79 1077 422 174 62 195 60 
H-negative risk:  640 653 1077 1135 422 420 79 83 195 174 60 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
206 
disease_progression 
H-positive risk:  655 641 83 1134 429 80 1075 411 173 62 200 57 
H-negative risk:  641 655 1075 1134 411 429 80 83 200 173 57 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
94 new agents 
207 
disease_progression 
H-positive risk:  656 631 83 1135 427 82 1091 408 170 61 199 57 
H-negative risk:  631 656 1091 1135 408 427 82 83 199 170 57 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
208 
disease_progression 
H-positive risk:  658 621 78 1145 428 83 1097 401 169 63 195 62 
H-negative risk:  621 658 1097 1145 401 428 83 78 195 169 62 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 83 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
209 
disease_progression 
H-positive risk:  664 629 80 1152 424 84 1081 404 167 64 193 58 
H-negative risk:  629 664 1081 1152 404 424 84 80 193 167 58 64 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 78 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
210 
disease_progression 
H-positive risk:  669 629 79 1152 419 85 1085 399 167 62 194 60 
H-negative risk:  629 669 1085 1152 399 419 85 79 194 167 60 62 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
211 
disease_progression 
H-positive risk:  663 631 79 1144 422 82 1091 404 169 61 193 61 
H-negative risk:  631 663 1091 1144 404 422 82 79 193 169 61 61 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
212 
disease_progression 
H-positive risk:  659 631 78 1145 421 82 1086 413 166 62 191 66 
H-negative risk:  631 659 1086 1145 413 421 82 78 191 166 66 62 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 73 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
213 
disease_progression 
H-positive risk:  661 625 84 1141 428 82 1080 414 167 60 190 68 
H-negative risk:  625 661 1080 1141 414 428 82 84 190 167 68 60 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
87 new agents 
214 
disease_progression 
H-positive risk:  656 637 82 1134 428 84 1077 415 171 61 188 67 
H-negative risk:  637 656 1077 1134 415 428 84 82 188 171 67 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
215 
disease_progression 
H-positive risk:  660 642 85 1135 421 87 1078 411 167 60 187 67 
H-negative risk:  642 660 1078 1135 411 421 87 85 187 167 67 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
216 
disease_progression 
H-positive risk:  660 647 86 1122 426 86 1080 411 165 61 190 66 
H-negative risk:  647 660 1080 1122 411 426 86 86 190 165 66 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
64 new agents 
217 
disease_progression 
H-positive risk:  663 652 87 1110 435 85 1076 415 161 64 188 64 
H-negative risk:  652 663 1076 1110 415 435 85 87 188 161 64 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
218 
disease_progression 
H-positive risk:  664 652 90 1117 431 83 1075 413 165 61 187 62 
H-negative risk:  652 664 1075 1117 413 431 83 90 187 165 62 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
87 new agents 
219 
disease_progression 
H-positive risk:  668 658 91 1110 432 82 1078 408 161 62 187 63 
H-negative risk:  658 668 1078 1110 408 432 82 91 187 161 63 62 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
88 new agents 
220 
disease_progression 
H-positive risk:  667 653 91 1112 427 82 1081 415 165 59 185 63 
H-negative risk:  653 667 1081 1112 415 427 82 91 185 165 63 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
221 
disease_progression 
H-positive risk:  666 653 89 1113 422 82 1082 414 167 60 188 64 
H-negative risk:  653 666 1082 1113 414 422 82 89 188 167 64 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
222 
disease_progression 
H-positive risk:  668 654 87 1112 424 81 1085 411 164 61 190 63 
H-negative risk:  654 668 1085 1112 411 424 81 87 190 164 63 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 78 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
223 
disease_progression 
H-positive risk:  672 658 87 1109 422 81 1079 415 165 61 190 61 
H-negative risk:  658 672 1079 1109 415 422 81 87 190 165 61 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
224 
disease_progression 
H-positive risk:  678 656 86 1101 419 81 1081 418 166 61 190 63 
H-negative risk:  656 678 1081 1101 418 419 81 86 190 166 63 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
225 
disease_progression 
H-positive risk:  684 657 84 1097 428 81 1077 415 164 64 185 64 
H-negative risk:  657 684 1077 1097 415 428 81 84 185 164 64 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
226 
disease_progression 
H-positive risk:  685 667 85 1101 429 79 1063 420 163 63 179 66 
H-negative risk:  667 685 1063 1101 420 429 79 85 179 163 66 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
227 
disease_progression 
H-positive risk:  683 666 84 1097 432 78 1072 423 164 60 178 63 
H-negative risk:  666 683 1072 1097 423 432 78 84 178 164 63 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
92 new agents 
228 
disease_progression 
H-positive risk:  677 672 86 1098 423 78 1077 423 165 59 179 63 
H-negative risk:  672 677 1077 1098 423 423 78 86 179 165 63 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
69 new agents 
229 
disease_progression 
H-positive risk:  674 674 86 1095 431 79 1064 427 166 59 179 66 
H-negative risk:  674 674 1064 1095 427 431 79 86 179 166 66 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
85 new agents 
230 
disease_progression 
H-positive risk:  677 676 80 1097 432 78 1069 415 165 61 186 64 
H-negative risk:  676 677 1069 1097 415 432 78 80 186 165 64 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 82 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
231 
disease_progression 
H-positive risk:  681 676 82 1088 435 79 1072 412 162 64 186 63 
H-negative risk:  676 681 1072 1088 412 435 79 82 186 162 63 64 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 86 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
232 
disease_progression 
H-positive risk:  682 675 80 1086 436 78 1072 414 164 61 189 63 
H-negative risk:  675 682 1072 1086 414 436 78 80 189 164 63 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
233 
disease_progression 
H-positive risk:  682 678 81 1091 426 78 1078 412 164 60 185 65 
H-negative risk:  678 682 1078 1091 412 426 78 81 185 164 65 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
234 
disease_progression 
H-positive risk:  678 680 80 1094 423 82 1083 408 162 64 183 63 
H-negative risk:  680 678 1083 1094 408 423 82 80 183 162 63 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
235 
disease_progression 
H-positive risk:  676 677 81 1093 421 83 1080 417 165 62 180 65 
H-negative risk:  677 676 1080 1093 417 421 83 81 180 165 65 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
236 
disease_progression 
H-positive risk:  673 685 82 1080 424 85 1086 415 168 59 181 62 
H-negative risk:  685 673 1086 1080 415 424 85 82 181 168 62 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
237 
disease_progression 
H-positive risk:  673 683 81 1081 426 84 1088 409 171 61 184 59 
H-negative risk:  683 673 1088 1081 409 426 84 81 184 171 59 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
238 
disease_progression 
H-positive risk:  668 687 84 1081 420 86 1087 412 170 61 186 58 
H-negative risk:  687 668 1087 1081 412 420 86 84 186 170 58 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
239 
disease_progression 
H-positive risk:  668 691 86 1078 428 87 1072 417 170 56 188 59 
H-negative risk:  691 668 1072 1078 417 428 87 86 188 170 59 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
240 
disease_progression 
H-positive risk:  676 700 84 1074 429 86 1066 415 168 58 185 59 
H-negative risk:  700 676 1066 1074 415 429 86 84 185 168 59 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
241 
disease_progression 
H-positive risk:  691 698 82 1047 441 86 1068 420 166 60 182 59 
H-negative risk:  698 691 1068 1047 420 441 86 82 182 166 59 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
93 new agents 
242 
disease_progression 
H-positive risk:  688 696 83 1050 439 86 1069 424 162 61 184 58 
H-negative risk:  696 688 1069 1050 424 439 86 83 184 162 58 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
243 
disease_progression 
H-positive risk:  685 697 80 1047 436 84 1074 425 163 63 186 60 
H-negative risk:  697 685 1074 1047 425 436 84 80 186 163 60 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
244 
disease_progression 
H-positive risk:  685 692 79 1050 431 84 1070 432 166 63 188 60 
H-negative risk:  692 685 1070 1050 432 431 84 79 188 166 60 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
245 
disease_progression 
H-positive risk:  685 686 81 1064 430 87 1070 420 166 61 191 59 
H-negative risk:  686 685 1070 1064 420 430 87 81 191 166 59 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
246 
disease_progression 
H-positive risk:  685 678 79 1063 432 87 1072 423 169 59 193 60 
H-negative risk:  678 685 1072 1063 423 432 87 79 193 169 60 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
247 
disease_progression 
H-positive risk:  681 691 78 1065 433 86 1075 413 164 62 191 61 
H-negative risk:  691 681 1075 1065 413 433 86 78 191 164 61 62 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
248 
disease_progression 
H-positive risk:  684 691 78 1056 431 84 1086 410 165 63 191 61 
H-negative risk:  691 684 1086 1056 410 431 84 78 191 165 61 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
249 
disease_progression 
H-positive risk:  685 693 86 1053 435 83 1077 409 166 63 188 62 
H-negative risk:  693 685 1077 1053 409 435 83 86 188 166 62 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
68 new agents 
250 
disease_progression 
H-positive risk:  683 695 87 1058 429 82 1072 414 164 65 187 64 
H-negative risk:  695 683 1072 1058 414 429 82 87 187 164 64 65 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
251 
disease_progression 
H-positive risk:  687 699 91 1061 426 86 1066 405 162 65 188 64 
H-negative risk:  699 687 1066 1061 405 426 86 91 188 162 64 65 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
88 new agents 
252 
disease_progression 
H-positive risk:  683 706 92 1049 434 87 1065 406 158 67 190 63 
H-negative risk:  706 683 1065 1049 406 434 87 92 190 158 63 67 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 91 29 

clinical_engagement 
diagnosis 
demography 
93 new agents 
253 
disease_progression 
H-positive risk:  687 706 90 1051 428 88 1070 404 156 68 191 61 
H-negative risk:  706 687 1070 1051 404 428 88 90 191 156 61 68 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 91 29 

clinical_engagement 
diagnosis 
demography 
104 new agents 
254 
disease_progression 
H-positive risk:  690 712 93 1044 428 87 1067 404 157 65 190 63 
H-negative risk:  712 690 1067 1044 404 428 87 93 190 157 63 65 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 87 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
255 
disease_progression 
H-positive risk:  691 715 92 1039 423 87 1080 396 158 63 192 64 
H-negative risk:  715 691 1080 1039 396 423 87 92 192 158 64 63 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
87 new agents 
256 
disease_progression 
H-positive risk:  695 722 93 1034 417 86 1073 403 159 65 187 66 
H-negative risk:  722 695 1073 1034 403 417 86 93 187 159 66 65 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 88 32 

clinical_engagement 
diagnosis 
demography 
64 new agents 
257 
disease_progression 
H-positive risk:  693 724 92 1029 428 82 1066 411 156 68 185 66 
H-negative risk:  724 693 1066 1029 411 428 82 92 185 156 66 68 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 88 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
258 
disease_progression 
H-positive risk:  684 725 91 1030 438 80 1077 397 157 69 187 65 
H-negative risk:  725 684 1077 1030 397 438 80 91 187 157 65 69 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
259 
disease_progression 
H-positive risk:  690 720 91 1039 442 79 1070 395 158 68 184 64 
H-negative risk:  720 690 1070 1039 395 442 79 91 184 158 64 68 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
260 
disease_progression 
H-positive risk:  688 725 88 1032 439 77 1069 405 159 69 188 61 
H-negative risk:  725 688 1069 1032 405 439 77 88 188 159 61 69 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 93 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
261 
disease_progression 
H-positive risk:  691 724 85 1039 439 79 1065 406 158 65 190 59 
H-negative risk:  724 691 1065 1039 406 439 79 85 190 158 59 65 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
262 
disease_progression 
H-positive risk:  698 715 84 1049 438 80 1064 404 154 69 191 54 
H-negative risk:  715 698 1064 1049 404 438 80 84 191 154 54 69 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
263 
disease_progression 
H-positive risk:  696 708 87 1047 441 84 1072 395 156 68 190 56 
H-negative risk:  708 696 1072 1047 395 441 84 87 190 156 56 68 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
264 
disease_progression 
H-positive risk:  705 715 90 1041 437 82 1068 398 156 66 183 59 
H-negative risk:  715 705 1068 1041 398 437 82 90 183 156 59 66 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
265 
disease_progression 
H-positive risk:  706 715 91 1037 441 81 1072 391 159 69 180 58 
H-negative risk:  715 706 1072 1037 391 441 81 91 180 159 58 69 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 94 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
266 
disease_progression 
H-positive risk:  702 711 90 1042 441 79 1079 391 163 67 177 58 
H-negative risk:  711 702 1079 1042 391 441 79 90 177 163 58 67 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 93 30 

clinical_engagement 
diagnosis 
demography 
94 new agents 
267 
disease_progression 
H-positive risk:  707 710 94 1046 432 83 1078 385 164 64 177 60 
H-negative risk:  710 707 1078 1046 385 432 83 94 177 164 60 64 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 96 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
268 
disease_progression 
H-positive risk:  703 708 94 1058 433 80 1077 380 165 68 178 56 
H-negative risk:  708 703 1077 1058 380 433 80 94 178 165 56 68 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 94 31 

clinical_engagement 
diagnosis 
demography 
59 new agents 
269 
disease_progression 
H-positive risk:  695 701 96 1057 441 76 1074 392 166 67 179 56 
H-negative risk:  701 695 1074 1057 392 441 76 96 179 166 56 67 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 95 32 

clinical_engagement 
diagnosis 
demography 
64 new agents 
270 
disease_progression 
H-positive risk:  702 700 99 1054 443 77 1075 384 165 67 176 58 
H-negative risk:  700 702 1075 1054 384 443 77 99 176 165 58 67 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 95 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
271 
disease_progression 
H-positive risk:  706 704 101 1048 427 76 1084 388 167 63 175 61 
H-negative risk:  704 706 1084 1048 388 427 76 101 175 167 61 63 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 93 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
272 
disease_progression 
H-positive risk:  710 696 104 1050 432 78 1087 385 161 63 173 61 
H-negative risk:  696 710 1087 1050 385 432 78 104 173 161 61 63 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 94 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
273 
disease_progression 
H-positive risk:  708 693 105 1049 440 79 1087 378 160 64 172 65 
H-negative risk:  693 708 1087 1049 378 440 79 105 172 160 65 64 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 93 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
274 
disease_progression 
H-positive risk:  714 686 104 1046 438 80 1091 380 159 65 176 61 
H-negative risk:  686 714 1091 1046 380 438 80 104 176 159 61 65 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 94 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
275 
disease_progression 
H-positive risk:  701 690 106 1042 438 81 1106 378 156 67 176 59 
H-negative risk:  690 701 1106 1042 378 438 81 106 176 156 59 67 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 95 31 

clinical_engagement 
diagnosis 
demography 
64 new agents 
276 
disease_progression 
H-positive risk:  709 690 105 1048 435 82 1100 372 155 66 178 60 
H-negative risk:  690 709 1100 1048 372 435 82 105 178 155 60 66 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 96 31 

clinical_engagement 
diagnosis 
demography 
91 new agents 
277 
disease_progression 
H-positive risk:  709 687 103 1054 433 81 1103 370 152 67 180 61 
H-negative risk:  687 709 1103 1054 370 433 81 103 180 152 61 67 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 97 32 

clinical_engagement 
diagnosis 
demography 
87 new agents 
278 
disease_progression 
H-positive risk:  707 689 100 1052 427 85 1106 371 149 65 181 68 
H-negative risk:  689 707 1106 1052 371 427 85 100 181 149 68 65 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 98 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
279 
disease_progression 
H-positive risk:  702 681 98 1057 423 87 1110 377 146 67 181 71 
H-negative risk:  681 702 1110 1057 377 423 87 98 181 146 71 67 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 97 32 

clinical_engagement 
diagnosis 
demography 
63 new agents 
280 
disease_progression 
H-positive risk:  701 669 99 1063 421 88 1115 378 144 69 181 72 
H-negative risk:  669 701 1115 1063 378 421 88 99 181 144 72 69 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 96 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
281 
disease_progression 
H-positive risk:  706 668 98 1061 424 90 1122 369 140 70 181 71 
H-negative risk:  668 706 1122 1061 369 424 90 98 181 140 71 70 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 96 32 

clinical_engagement 
diagnosis 
demography 
76 new agents 
282 
disease_progression 
H-positive risk:  708 678 101 1055 416 88 1118 379 140 70 177 70 
H-negative risk:  678 708 1118 1055 379 416 88 101 177 140 70 70 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 97 32 

clinical_engagement 
diagnosis 
demography 
61 new agents 
283 
disease_progression 
H-positive risk:  709 680 99 1057 414 87 1116 380 142 69 177 70 
H-negative risk:  680 709 1116 1057 380 414 87 99 177 142 70 69 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 97 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
284 
disease_progression 
H-positive risk:  707 685 97 1064 411 87 1110 382 143 68 178 68 
H-negative risk:  685 707 1110 1064 382 411 87 97 178 143 68 68 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 98 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
285 
disease_progression 
H-positive risk:  706 681 96 1060 415 93 1106 389 143 65 179 67 
H-negative risk:  681 706 1106 1060 389 415 93 96 179 143 67 65 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 96 33 

clinical_engagement 
diagnosis 
demography 
84 new agents 
286 
disease_progression 
H-positive risk:  712 684 97 1057 413 93 1107 387 146 63 175 66 
H-negative risk:  684 712 1107 1057 387 413 93 97 175 146 66 63 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 95 33 

clinical_engagement 
diagnosis 
demography 
86 new agents 
287 
disease_progression 
H-positive risk:  717 673 96 1061 421 94 1099 384 149 64 174 68 
H-negative risk:  673 717 1099 1061 384 421 94 96 174 149 68 64 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 93 33 

clinical_engagement 
diagnosis 
demography 
78 new agents 
288 
disease_progression 
H-positive risk:  722 669 94 1063 421 92 1096 388 148 63 175 69 
H-negative risk:  669 722 1096 1063 388 421 92 94 175 148 69 63 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 92 34 

clinical_engagement 
diagnosis 
demography 
65 new agents 
289 
disease_progression 
H-positive risk:  730 667 95 1057 423 93 1089 398 147 63 172 66 
H-negative risk:  667 730 1089 1057 398 423 93 95 172 147 66 63 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 93 34 

clinical_engagement 
diagnosis 
demography 
66 new agents 
290 
disease_progression 
H-positive risk:  729 669 93 1064 423 89 1086 399 145 64 174 65 
H-negative risk:  669 729 1086 1064 399 423 89 93 174 145 65 64 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 95 33 

clinical_engagement 
diagnosis 
demography 
77 new agents 
291 
disease_progression 
H-positive risk:  733 670 95 1057 419 91 1088 400 146 66 171 64 
H-negative risk:  670 733 1088 1057 400 419 91 95 171 146 64 66 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 94 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
292 
disease_progression 
H-positive risk:  733 668 96 1058 423 92 1089 399 144 65 168 65 
H-negative risk:  668 733 1089 1058 399 423 92 96 168 144 65 65 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 93 27 

clinical_engagement 
diagnosis 
demography 
57 new agents 
293 
disease_progression 
H-positive risk:  734 664 93 1057 417 95 1088 405 145 67 171 64 
H-negative risk:  664 734 1088 1057 405 417 95 93 171 145 64 67 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 92 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
294 
disease_progression 
H-positive risk:  744 658 92 1060 411 95 1091 408 144 66 167 64 
H-negative risk:  658 744 1091 1060 408 411 95 92 167 144 64 66 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 93 31 

clinical_engagement 
diagnosis 
demography 
55 new agents 
295 
disease_progression 
H-positive risk:  738 659 93 1057 416 94 1099 407 144 64 166 63 
H-negative risk:  659 738 1099 1057 407 416 94 93 166 144 63 64 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 94 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
296 
disease_progression 
H-positive risk:  730 663 94 1067 415 89 1099 407 144 65 163 64 
H-negative risk:  663 730 1099 1067 407 415 89 94 163 144 64 65 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 88 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
297 
disease_progression 
H-positive risk:  739 668 93 1057 417 87 1096 407 145 64 164 63 
H-negative risk:  668 739 1096 1057 407 417 87 93 164 145 63 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 86 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
298 
disease_progression 
H-positive risk:  731 669 93 1061 417 88 1100 405 148 61 160 67 
H-negative risk:  669 731 1100 1061 405 417 88 93 160 148 67 61 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 88 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
299 
disease_progression 
H-positive risk:  724 679 92 1062 414 87 1104 400 148 61 161 68 
H-negative risk:  679 724 1104 1062 400 414 87 92 161 148 68 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 87 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
300 
disease_progression 
H-positive risk:  725 681 90 1061 413 86 1107 399 150 61 156 71 
H-negative risk:  681 725 1107 1061 399 413 86 90 156 150 71 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
301 
disease_progression 
H-positive risk:  732 678 93 1062 413 88 1103 397 147 63 154 70 
H-negative risk:  678 732 1103 1062 397 413 88 93 154 147 70 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
302 
disease_progression 
H-positive risk:  736 680 95 1057 410 92 1102 392 143 63 160 70 
H-negative risk:  680 736 1102 1057 392 410 92 95 160 143 70 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
81 new agents 
303 
disease_progression 
H-positive risk:  732 672 97 1067 413 92 1103 392 141 63 158 70 
H-negative risk:  672 732 1103 1067 392 413 92 97 158 141 70 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
55 new agents 
304 
disease_progression 
H-positive risk:  729 679 95 1062 423 89 1106 385 144 59 161 68 
H-negative risk:  679 729 1106 1062 385 423 89 95 161 144 68 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
305 
disease_progression 
H-positive risk:  724 682 97 1058 421 91 1106 388 145 57 162 69 
H-negative risk:  682 724 1106 1058 388 421 91 97 162 145 69 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
306 
disease_progression 
H-positive risk:  726 679 98 1066 413 91 1110 387 145 56 158 71 
H-negative risk:  679 726 1110 1066 387 413 91 98 158 145 71 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
88 new agents 
307 
disease_progression 
H-positive risk:  727 679 100 1067 417 88 1099 395 143 57 157 71 
H-negative risk:  679 727 1099 1067 395 417 88 100 157 143 71 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
63 new agents 
308 
disease_progression 
H-positive risk:  726 677 101 1068 419 87 1095 400 145 57 152 73 
H-negative risk:  677 726 1095 1068 400 419 87 101 152 145 73 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
309 
disease_progression 
H-positive risk:  734 672 104 1071 415 89 1095 398 144 59 148 71 
H-negative risk:  672 734 1095 1071 398 415 89 104 148 144 71 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
310 
disease_progression 
H-positive risk:  732 661 106 1091 404 90 1097 402 142 59 146 70 
H-negative risk:  661 732 1097 1091 402 404 90 106 146 142 70 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
311 
disease_progression 
H-positive risk:  731 662 105 1088 402 93 1095 409 141 57 148 69 
H-negative risk:  662 731 1095 1088 409 402 93 105 148 141 69 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
312 
disease_progression 
H-positive risk:  725 666 106 1084 411 95 1094 414 138 56 142 69 
H-negative risk:  666 725 1094 1084 414 411 95 106 142 138 69 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
313 
disease_progression 
H-positive risk:  718 658 107 1086 419 97 1082 429 136 57 141 70 
H-negative risk:  658 718 1082 1086 429 419 97 107 141 136 70 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
314 
disease_progression 
H-positive risk:  702 662 107 1081 426 97 1095 426 136 57 138 73 
H-negative risk:  662 702 1095 1081 426 426 97 107 138 136 73 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
315 
disease_progression 
H-positive risk:  698 666 105 1087 424 94 1095 423 135 58 139 76 
H-negative risk:  666 698 1095 1087 423 424 94 105 139 135 76 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
316 
disease_progression 
H-positive risk:  699 666 104 1085 419 94 1099 427 134 59 138 76 
H-negative risk:  666 699 1099 1085 427 419 94 104 138 134 76 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
93 new agents 
317 
disease_progression 
H-positive risk:  696 674 104 1081 426 95 1106 420 135 54 136 73 
H-negative risk:  674 696 1106 1081 420 426 95 104 136 135 73 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
318 
disease_progression 
H-positive risk:  687 667 102 1095 424 94 1102 428 137 53 138 73 
H-negative risk:  667 687 1102 1095 428 424 94 102 138 137 73 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
319 
disease_progression 
H-positive risk:  689 669 104 1093 426 91 1105 425 136 52 137 73 
H-negative risk:  669 689 1105 1093 425 426 91 104 137 136 73 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
320 
disease_progression 
H-positive risk:  683 670 103 1097 428 86 1110 428 137 52 132 74 
H-negative risk:  670 683 1110 1097 428 428 86 103 132 137 74 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
321 
disease_progression 
H-positive risk:  684 666 104 1089 437 85 1112 428 135 54 132 74 
H-negative risk:  666 684 1112 1089 428 437 85 104 132 135 74 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
322 
disease_progression 
H-positive risk:  681 671 105 1099 427 85 1110 425 137 51 135 74 
H-negative risk:  671 681 1110 1099 425 427 85 105 135 137 74 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
323 
disease_progression 
H-positive risk:  685 673 105 1098 431 87 1107 417 136 51 138 72 
H-negative risk:  673 685 1107 1098 417 431 87 105 138 136 72 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
324 
disease_progression 
H-positive risk:  680 677 107 1090 439 86 1103 418 139 50 141 70 
H-negative risk:  677 680 1103 1090 418 439 86 107 141 139 70 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
325 
disease_progression 
H-positive risk:  680 672 106 1096 434 85 1100 422 143 50 141 71 
H-negative risk:  672 680 1100 1096 422 434 85 106 141 143 71 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
326 
disease_progression 
H-positive risk:  673 673 107 1105 433 83 1101 422 139 54 139 71 
H-negative risk:  673 673 1101 1105 422 433 83 107 139 139 71 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
94 new agents 
327 
disease_progression 
H-positive risk:  673 675 106 1094 441 83 1104 419 144 51 141 69 
H-negative risk:  675 673 1104 1094 419 441 83 106 141 144 69 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
328 
disease_progression 
H-positive risk:  670 676 108 1096 438 84 1106 420 145 50 141 66 
H-negative risk:  676 670 1106 1096 420 438 84 108 141 145 66 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
329 
disease_progression 
H-positive risk:  680 676 108 1090 444 87 1107 413 146 46 136 67 
H-negative risk:  676 680 1107 1090 413 444 87 108 136 146 67 46 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
330 
disease_progression 
H-positive risk:  678 670 108 1099 441 88 1114 412 143 47 134 66 
H-negative risk:  670 678 1114 1099 412 441 88 108 134 143 66 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
331 
disease_progression 
H-positive risk:  683 668 109 1104 433 89 1106 417 143 47 133 68 
H-negative risk:  668 683 1106 1104 417 433 89 109 133 143 68 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
332 
disease_progression 
H-positive risk:  682 658 110 1104 430 89 1107 424 143 47 136 70 
H-negative risk:  658 682 1107 1104 424 430 89 110 136 143 70 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
333 
disease_progression 
H-positive risk:  679 656 107 1101 433 90 1112 421 142 50 137 72 
H-negative risk:  656 679 1112 1101 421 433 90 107 137 142 72 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
334 
disease_progression 
H-positive risk:  675 654 107 1119 433 89 1112 416 138 51 137 69 
H-negative risk:  654 675 1112 1119 416 433 89 107 137 138 69 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
335 
disease_progression 
H-positive risk:  671 653 108 1123 434 91 1111 413 137 52 139 68 
H-negative risk:  653 671 1111 1123 413 434 91 108 139 137 68 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
336 
disease_progression 
H-positive risk:  669 657 106 1123 432 93 1119 408 139 50 139 65 
H-negative risk:  657 669 1119 1123 408 432 93 106 139 139 65 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
337 
disease_progression 
H-positive risk:  660 657 102 1133 432 93 1127 408 135 50 138 65 
H-negative risk:  657 660 1127 1133 408 432 93 102 138 135 65 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
338 
disease_progression 
H-positive risk:  667 653 101 1138 424 92 1119 418 135 49 137 67 
H-negative risk:  653 667 1119 1138 418 424 92 101 137 135 67 49 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
339 
disease_progression 
H-positive risk:  665 661 98 1137 425 90 1116 418 131 50 140 69 
H-negative risk:  661 665 1116 1137 418 425 90 98 140 131 69 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
340 
disease_progression 
H-positive risk:  667 659 100 1143 424 91 1098 432 132 51 137 66 
H-negative risk:  659 667 1098 1143 432 424 91 100 137 132 66 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
341 
disease_progression 
H-positive risk:  663 655 99 1142 431 92 1097 436 134 51 135 65 
H-negative risk:  655 663 1097 1142 436 431 92 99 135 134 65 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
342 
disease_progression 
H-positive risk:  665 651 99 1141 423 91 1099 441 136 55 135 64 
H-negative risk:  651 665 1099 1141 441 423 91 99 135 136 64 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
343 
disease_progression 
H-positive risk:  668 649 100 1134 428 91 1098 444 134 55 135 64 
H-negative risk:  649 668 1098 1134 444 428 91 100 135 134 64 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
344 
disease_progression 
H-positive risk:  672 650 101 1136 427 92 1097 440 132 58 134 61 
H-negative risk:  650 672 1097 1136 440 427 92 101 134 132 61 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
345 
disease_progression 
H-positive risk:  678 659 100 1133 423 91 1092 444 130 57 133 60 
H-negative risk:  659 678 1092 1133 444 423 91 100 133 130 60 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
346 
disease_progression 
H-positive risk:  681 659 100 1133 424 87 1093 444 129 60 133 57 
H-negative risk:  659 681 1093 1133 444 424 87 100 133 129 57 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
347 
disease_progression 
H-positive risk:  682 659 101 1124 434 87 1096 438 128 62 134 55 
H-negative risk:  659 682 1096 1124 438 434 87 101 134 128 55 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
348 
disease_progression 
H-positive risk:  692 655 101 1134 419 88 1092 435 129 64 136 55 
H-negative risk:  655 692 1092 1134 435 419 88 101 136 129 55 64 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
349 
disease_progression 
H-positive risk:  692 658 102 1132 413 87 1091 436 131 64 138 56 
H-negative risk:  658 692 1091 1132 436 413 87 102 138 131 56 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
350 
disease_progression 
H-positive risk:  687 661 105 1125 413 86 1105 426 132 66 138 56 
H-negative risk:  661 687 1105 1125 426 413 86 105 138 132 56 66 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
351 
disease_progression 
H-positive risk:  689 655 104 1123 410 88 1112 429 131 67 135 57 
H-negative risk:  655 689 1112 1123 429 410 88 104 135 131 57 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
352 
disease_progression 
H-positive risk:  689 655 105 1117 410 88 1112 434 132 68 134 56 
H-negative risk:  655 689 1112 1117 434 410 88 105 134 132 56 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
353 
disease_progression 
H-positive risk:  693 642 104 1122 415 88 1110 435 134 64 135 58 
H-negative risk:  642 693 1110 1122 435 415 88 104 135 134 58 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
354 
disease_progression 
H-positive risk:  689 638 105 1121 425 89 1116 429 132 65 133 58 
H-negative risk:  638 689 1116 1121 429 425 89 105 133 132 58 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
355 
disease_progression 
H-positive risk:  693 643 108 1102 432 90 1111 434 136 60 134 57 
H-negative risk:  643 693 1111 1102 434 432 90 108 134 136 57 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
356 
disease_progression 
H-positive risk:  698 642 109 1106 441 90 1102 427 136 57 134 58 
H-negative risk:  642 698 1102 1106 427 441 90 109 134 136 58 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
357 
disease_progression 
H-positive risk:  703 647 111 1103 440 91 1102 417 135 56 136 59 
H-negative risk:  647 703 1102 1103 417 440 91 111 136 135 59 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
358 
disease_progression 
H-positive risk:  707 648 112 1102 438 92 1100 416 137 54 134 60 
H-negative risk:  648 707 1100 1102 416 438 92 112 134 137 60 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
359 
disease_progression 
H-positive risk:  714 645 110 1102 434 91 1096 421 137 54 135 61 
H-negative risk:  645 714 1096 1102 421 434 91 110 135 137 61 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
360 
disease_progression 
H-positive risk:  710 647 110 1091 433 93 1104 423 140 53 139 57 
H-negative risk:  647 710 1104 1091 423 433 93 110 139 140 57 53 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
Time difference of 22.76224 mins
This is task 5
date
